期刊文献+

部分黄酮类化合物的Ⅱ相代谢产物及其药理活性研究进展 被引量:11

Phase II metabolites of several flavonoids and their pharmacological activities
原文传递
导出
摘要 黄酮类化合物为一大类广泛存在于食物和药物中的天然产物,具有多种药理作用。近来研究表明黄酮类化合物在体内主要以苷元的Ⅱ相代谢产物形式存在,包括不同取代位点的一系列苷元的葡糖醛酸苷、硫酸酯及混合结合物。其中一些Ⅱ相代谢产物已被证明具有抗炎、抗氧化、抗肿瘤、影响代谢酶和转运体等方面的药理活性。文中对文献报道的黄酮、异黄酮、黄酮醇、二氢黄酮、黄烷-3-醇和花色素等黄酮类化合物的Ⅱ相代谢产物及其药理作用进行了综述。 Flavonoids are a large category of natural products present in foods and drugs with diverse pharmacological activities.Recent researches suggest that flavonoids exist in vivo mainly as their phase II metabolites including a series of aglycone glucuronides,sulfates and their mixtures.Some of them have been proved to possess some pharmacological activities like anti-inflammatory,anti-oxidant,and anti-tumor effects and can interact with metabolic enzymes and transporters.This review discusses the previous researches on phase II metabolites of flavonoids include flavones,isoflavones,flavonols,flavonones,flavan-3-ols and anthocyanidins and their pharmacological activities.
出处 《中国新药杂志》 CAS CSCD 北大核心 2012年第2期144-150,共7页 Chinese Journal of New Drugs
关键词 黄酮类化合物 Ⅱ相代谢产物 药理活性 flavonoids phase Ⅱ metabolites pharmacological activities
  • 相关文献

参考文献59

  • 1GRASSI D, DESIDERI G, CROCE G, et al. Flavonoids, vascular function and cardiovascular protection [ J ]. Curr Pharm Des, 2009, 15 (10) : 1072 - 1084.
  • 2GARCIA-LAFUENTE A, GUILLAMON E, VILLARES A, et al. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease [ J ]. Inflamm Res, 2009, 58 ( 9 ) : 537 -552.
  • 3GRADOLATTO A, CANIVENC-LAVIER MC, BASLY JP, et al. Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver[ J]. Drug Metab Dispos, 2004, 32(1): 58-65.
  • 4ZUO Z, ZHANG L, ZHOU L, et al. Intestinal absorption of hawthorn flavonoids-in vitro, in situ and in vivo correlations [ J ]. Life Sci, 2006, 79(26) : 2455 -2462.
  • 5YASUDA T, KANO Y, SAITO K, et al. Urinary and biliary metabolites of puerarin in rats [ J ]. Biol Pharm Bull, 1995, 18 (2): 300-303.
  • 6JAGANATI-I IB, MULLEN W, EDWARDS CA, et al. The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man [ J]. Free Radic Res, 2006, 40 (10) : 1035 -1046.
  • 7REINBOTH M, WOLFFRAM S, ABRAHAM G, et al. Oral bioavailability of quercetin from different quercetin glycesides in dogs [J]. Br JNutr, 2010, 104(2): 198 -203.
  • 8MULLEN W, EDWARDS CA, CROZIER A. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions[J]. Br J Nutr, 2006, 96(1): 107 -116.
  • 9HOSODA K, FURUTA T, YOKOKAWA A, et al. Identification and quantification of daidzein-7-glucuronide4'-sulfate, genistein- 7-glucuronide-4'-sulfate and genistein-4',7-diglucuronide as major metabolites in human plasma after administration of kinako [J]. Anal Bioanal Chem, 2010, 397(4) : 1563 -1572.
  • 10AZZINI E, VITAGLIONE P, INTORRE F, et al. Bioavailability of strawberry antioxidants in human subjects [ J ]. Br J Nutr, 2010, 104(8): 1165-1173.

二级参考文献9

  • 1毛凤斐 朱家壁 等.黄芩甙人体内吸收研究[J].中成药研究,1981,12:6-6.
  • 2小桥恭一.-[J].和汉医药杂志,1998,15(1):1-1.
  • 3Zhou Y J,Pharmazie,2000年,55卷,8期,626页
  • 4小桥恭一,和汉医药学杂志,1998年,15卷,1期,1页
  • 5王本祥,现代中药药理学,1997年,301,299页
  • 6中国药典.一部,1995年,270页
  • 7Abe K,Chem Pharm Bull,1990年,38卷,1期,208页
  • 8毛凤斐,中成药研究,1981年,12卷,6页
  • 9赵科社.黄芩甙生产工艺改进[J].中成药,1990,12(11):2-3. 被引量:6

共引文献72

同被引文献117

引证文献11

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部